These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 1525456)

  • 1. Leuprolide acetate elevates prolactin during ovarian stimulation with gonadotropins.
    Meldrum DR; Cedars MI; Hamilton F; Huynh D; Wisot A; Marr B
    J Assist Reprod Genet; 1992 Jun; 9(3):251-3. PubMed ID: 1525456
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Luteinizing response to human chorionic gonadotropin does not predict outcome in gonadotropin releasing hormone agonist-suppressed/human menopausal gonadotropin-stimulated in vitro fertilization (IVF) cycles.
    Penzias AS; Shamma FN; Gutmann JN; Seifer DB; DeCherney AH; Lavy G
    J Assist Reprod Genet; 1992 Jun; 9(3):244-7. PubMed ID: 1525454
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Performance of cryopreserved pre-embryos obtained in in vitro fertilization cycles with or without a gonadotropin-releasing hormone agonist.
    Oehninger S; Toner JP; Veeck LL; Brzyski RG; Acosta AA; Muasher SJ
    Fertil Steril; 1992 Mar; 57(3):620-5. PubMed ID: 1740208
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessing the adequacy of gonadotropin-releasing hormone agonist leuprolide to trigger oocyte maturation and management of inadequate response.
    Chang FE; Beall SA; Cox JM; Richter KS; DeCherney AH; Levy MJ
    Fertil Steril; 2016 Oct; 106(5):1093-1100.e3. PubMed ID: 27341988
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gonadotropin-releasing hormone agonist versus human chorionic gonadotropin for triggering follicular maturation in in vitro fertilization.
    Segal S; Casper RF
    Fertil Steril; 1992 Jun; 57(6):1254-8. PubMed ID: 1601147
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of intermittent and continuous use of a gonadotropin-releasing hormone antagonist (Nal-Glu) in in vitro fertilization cycles: a preliminary report.
    Cassidenti DL; Sauer MV; Paulson RJ; Ditkoff EC; Rivier J; Yen SS; Lobo RA
    Am J Obstet Gynecol; 1991 Dec; 165(6 Pt 1):1806-10. PubMed ID: 1750479
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Leuprolide acetate-prepared in vitro fertilization-gamete intrafallopian transfer cycles: efficacy versus controls and cost analysis.
    Corson SL; Batzer FR; Gocial B; Eisenberg E; Huppert LC; Nelson JR
    Fertil Steril; 1992 Mar; 57(3):601-5. PubMed ID: 1740205
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Triggering with human chorionic gonadotropin or a gonadotropin-releasing hormone agonist in gonadotropin-releasing hormone antagonist-treated oocyte donor cycles: findings of a large retrospective cohort study.
    Bodri D; Guillén JJ; Galindo A; Mataró D; Pujol A; Coll O
    Fertil Steril; 2009 Feb; 91(2):365-71. PubMed ID: 18367175
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Leuprolide acetate lowers circulating bioactive luteinizing hormone and testosterone concentrations during ovarian stimulation for oocyte retrieval.
    Cedars MI; Surey E; Hamilton F; Lapolt P; Meldrum DR
    Fertil Steril; 1990 Apr; 53(4):627-31. PubMed ID: 2108057
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gonadotropin and estradiol levels during ovarian stimulation in women treated with leuprolide acetate.
    Stone BA; Serafini PC; Quinn K; Quinn P; Kerin JF; Marrs RP
    Obstet Gynecol; 1989 Jun; 73(6):990-5. PubMed ID: 2498795
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dual trigger with gonadotropin-releasing hormone agonist and recombinant human chorionic gonadotropin improves in vitro fertilization outcome in gonadotropin-releasing hormone antagonist cycles.
    Seval MM; Özmen B; Atabekoğlu C; Şükür YE; Şimşir C; Kan Ö; Sönmezer M
    J Obstet Gynaecol Res; 2016 Sep; 42(9):1146-51. PubMed ID: 27199084
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Routine pituitary suppression with leuprolide before ovarian stimulation for oocyte retrieval.
    Meldrum DR; Wisot A; Hamilton F; Gutlay AL; Kempton WF; Huynh D
    Fertil Steril; 1989 Mar; 51(3):455-9. PubMed ID: 2493403
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lower pregnancy rate with premature luteinization during pituitary suppression with leuprolide acetate.
    Schoolcraft W; Sinton E; Schlenker T; Huynh D; Hamilton F; Meldrum DR
    Fertil Steril; 1991 Mar; 55(3):563-6. PubMed ID: 1900481
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gonadotropin-releasing hormone agonist or human chorionic gonadotropin for final oocyte maturation in an oocyte donor program.
    Erb TM; Vitek W; Wakim AN
    Fertil Steril; 2010 Feb; 93(2):374-8. PubMed ID: 19171336
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A combination of norethindrone acetate and leuprolide acetate blocks the gonadotrophin-releasing hormone agonistic response and minimizes cyst formation during ovarian stimulation.
    Ditkoff EC; Sauer MV
    Hum Reprod; 1996 May; 11(5):1035-7. PubMed ID: 8671386
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Flexibility in starting ovarian stimulation at different phases of the menstrual cycle for treatment of infertile women with the use of in vitro fertilization or intracytoplasmic sperm injection.
    Qin N; Chen Q; Hong Q; Cai R; Gao H; Wang Y; Sun L; Zhang S; Guo H; Fu Y; Ai A; Tian H; Lyu Q; Daya S; Kuang Y
    Fertil Steril; 2016 Aug; 106(2):334-341.e1. PubMed ID: 27114329
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of leuprolide acetate and gonadotropins versus clomiphene citrate and gonadotropins for in vitro fertilization or gamete intrafallopian transfer.
    Ferrier A; Rasweiler JJ; Bedford JM; Prey K; Berkeley AS
    Fertil Steril; 1990 Jul; 54(1):90-5. PubMed ID: 2113492
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of human menopausal gonadotropin and follicle-stimulating hormone with gonadotropin-releasing hormone agonist desensitization for controlled ovarian hyperstimulation in in vitro fertilization.
    Yang TS; Wang BC; Chang SP; Ng HT
    Zhonghua Yi Xue Za Zhi (Taipei); 1995 Jun; 55(6):452-6. PubMed ID: 7634183
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevention of ovarian hyperstimulation syndrome.
    Amso NN; Shaw RW; Ahuja KK; Morris N
    Fertil Steril; 1991 Jan; 55(1):220-1. PubMed ID: 1986965
    [No Abstract]   [Full Text] [Related]  

  • 20. Leuprolide acetate for inducing ovulation in women undergoing ovarian stimulation.
    diDonato P; Nola VF; Pittman TV; Marr V; Stubbs C; Meldrum DR
    J Reprod Med; 1995 Oct; 40(10):715-6. PubMed ID: 8551474
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.